Jump to content

Bernard Salick

Add links
From Wikipedia, the free encyclopedia
Bernard Salick
Born1939 (age 84–85)
New York City, New York, US
EducationQueens College (1960)
University of Southern California (1964)
Occupation(s)Nephrologist, Entrepreneur
Medical career
ProfessionDoctor
FieldDisease-state management
Institutions

Bernard Salick (born 1939) is an American nephrologist and medical entrepreneur known for his contributions to comprehensive disease-state management and his efforts to reduce the costs of cancer treatment.[1] He is the founder and former CEO and chairman of Salick Health Care,[2] a national disease management company in the United States.[3][4][5] While leading the company, Salick created a managed care subsidiary, the first to offer fixed-price insurance products for the treatment of catastrophic diseases such as cancer and end-stage renal disease.[6][7]

Since 2016, Salick serves as a Professor of Medicine at Cedars-Sinai Medical Center in Los Angeles, California.

Early life and education

[edit]

Salick was born in New York City in 1939.[8] He graduated from Queens College with a BS degree in 1960, then studied medicine at the University of Southern California, where he earned his M.D. in 1964.[9]

Career

[edit]

Salick completed an internship and residency in Internal Medicine at Cedars-Sinai Medical Center and a National Institutes of Health postdoctoral fellowship in Nephrology at Cedars-Sinai Medical Center and the University of California, Los Angeles.[9] After starting his nephrology practice in Beverly Hills, Salick opened a chain of dialysis clinics in 1972. He was elected to the board of trustees for the Hereditary Disease Foundation in 1975, where he served until 1985. He was also a member of the National Advisory Board for the National Kidney Foundation from 1988 to 1990.[8]

In 1975, Salick sold his dialysis chain to Damon Corp.[10] In 1983, he bought it back and founded a new company called Salick Health Care. He decided to start a new chain of outpatient cancer care clinics when his 6-year-old daughter was diagnosed with a sarcoma.[11][12] He opened his first cancer center at Cedars-Sinai Medical Center in Los Angeles in 1985.[13] By 1989, the company operated seven cancer care centers in partnership with major non-profit teaching hospitals including Temple University Hospital.[8] In the 1990s, the company expanded to a chain of 11 outpatient comprehensive cancer centers, 8 breast cancer treatment centers as well as multiple dialysis centers in Southern California, Florida, Philadelphia and New York.[14][15][16]

Salick Health Care went public in March 1985 raising $18 million, and another $30 million in 1986 through a bond offering. In 1995, the company sold 50 percent of its shares to Zeneca Group (now AstraZeneca)[17] which eventually acquired Salick Health Care in 1997 in a deal worth $450 million.[18][19][20]

In 1997, Salick started Bentley Health Care providing diagnostic and therapeutic services to patients with chronic, catastrophic illnesses such as cancer, end-stage renal disease, and AIDS.[1][21] He went into partnership with Montefiore Medical Center and Mount Sinai Medical Center to open outpatient cancer clinics and HIV/AIDS centers in New York and Florida.[1]

In April 1997, Salick donated $4.5 million to Queens College to create a new molecular biology research institute focusing initially on HIV/AIDS and hired Professor Luc Montagnier, co-discoverer of the AIDS virus to join as its first endowed chair.[22][23] Dr. Salick demanded and received the return of $3 million of his gift from the school when it failed to meet the conditions that had been attached to the gift.[24]

In 2006, Salick founded Salick Cardiovascular Centers to provide diagnostic and treatment services for cardiovascular disease. He is currently working on the development of a nationwide program of Comprehensive Diabetes Centers.[25]

Other activities

[edit]

In 2004, Salick established the Bernard and Gloria Salick Fellowship in Public Health at Harvard School of Public Health to provide annual scholarships for students pursuing careers in comprehensive disease management in catastrophic illnesses such as cancer and heart disease.[26][27] He was a member of the Visiting Committee and the Leadership Council of the Harvard School of Public Health. In 2005, he served on the Harvard Business School panel for Healthcare Innovation and Opportunities in Southeast Asia and was a member of its Healthcare Initiative Advisory Board and the Centennial Committee in 2008.'

From 2005 to 2007, Salick served on the Board of Directors of Nephros, Inc.[28] and in addition, he served as a member of the board of trustees for the United States Equestrian Team Foundation from 1991 to 2011.[29] He has also served on the board of the Queens College Foundation, and Crossroads School for Arts and Sciences in Santa Monica.[30]

Salick's horse ranch in Hidden Valley, California, was offered for sale in 2002 for $50 million.[31] The same property was offered for sale in 2016 for $32 million.[32]

Salick partnered with David Geffen to develop a 4-story 175,000 square foot luxury office building in Beverly Hills, California, which was sold in 2005 for $71 million to Tishman Speyer Properties.[33]

References

[edit]
  1. ^ a b c Bianco, Anthony (June 22, 1998). "Bernie Salick's Business Is Cancer". Bloomberg. Retrieved March 30, 2019.
  2. ^ WHITE, GEORGE (September 19, 1988). "For Salick Centers, Treating Cancer Is a 24-Hour Battle". Los Angeles Times. Retrieved March 30, 2019.
  3. ^ OLMOS, DAVID R. (March 28, 1997). "Zeneca to Buy Remaining Stake of Salick". Los Angeles Times. Retrieved March 30, 2019.
  4. ^ OLMOS, DAVID R. (April 15, 1997). "Zeneca Group Ousts Founder of Salick Health". Los Angeles Times. Retrieved March 30, 2019.
  5. ^ Smigel, K. (1989-02-01). "Administrative Remedies Proposed for the NIH". JNCI Journal of the National Cancer Institute. 81 (3): 185–187. doi:10.1093/jnci/81.3.185. ISSN 0027-8874.
  6. ^ Rundle, Rhonda L. (August 12, 1996). "Salick Is Pioneering Selling Cancer Treatment to HMOs". The Wall Street Journal. Archived from the original on June 29, 2018. Retrieved March 30, 2019.
  7. ^ "Zeneca Expands Into Health-Care Services With Salick Purchase". Oncology NEWS International Vol 4 No 2. 4 (2). February 1, 1995. Retrieved March 30, 2019. {{cite journal}}: Cite journal requires |journal= (help)
  8. ^ a b c "Salick Health Care, Inc. -". Retrieved March 30, 2019.
  9. ^ a b "Bernard Salick - Queens College/CUNY". qccommunity.qc.cuny.edu. Retrieved March 30, 2019.
  10. ^ "Salick Health Care, Inc. -- Company History". Retrieved March 30, 2019.
  11. ^ Moffat, Susan (January 24, 1993). "Healing the State's Ailing Job Market : Health Care Is Bright Spot Amid Gloom". Los Angeles Times. Retrieved March 30, 2019.
  12. ^ Rice, Trudy Thompson (March 5, 1997). "The King of Cancer". Hospitals & Health Networks. 71 (5): 34–38. PMID 9074359.
  13. ^ Lev, Michael (May 21, 1991). "MARKET PLACE; Salick's Growing Health Care Niche". The New York Times. Retrieved March 30, 2019.
  14. ^ SOMMER, CONSTANCE (October 17, 1993). "New $10-Million Cancer Center to Open : Medicine: Westlake Medical Center is hopeful the treatment facility will lure Valley patients from other local hospitals". Los Angeles Times. Retrieved March 30, 2019.
  15. ^ Lagnado, Lucette (August 12, 1996). "Planned New York Center Sends Shivers Through Competitors". The Wall Street Journal. Retrieved March 30, 2019.
  16. ^ Rosenthal, Elisabeth (September 8, 1996). "A Pushy Newcomer Shakes Up Cancer Treatment in New York". The New York Times. Retrieved March 30, 2019.
  17. ^ Hilzenrath, David S. (December 23, 1994). "Drugmaker to enter care field Zeneca buyinh 50 pct. stake in Salick Cancer treatment chain". The Washington Post. Archived from the original on March 30, 2019. Retrieved March 30, 2019.
  18. ^ OLMOS, DAVID R. (April 4, 1997). "Zeneca Group Ousts Founder of Salick Health". Los Angeles Times. ISSN 0458-3035. Retrieved March 30, 2019.
  19. ^ Firshein, Janet (1997). "Drug firm buys up chain of US cancer clinics". The Lancet. 349 (9060): 1230. doi:10.1016/S0140-6736(05)62431-2. ISSN 0140-6736. S2CID 53216930. Retrieved March 30, 2019.
  20. ^ "Salick to compete with Zeneca after abrupt departure". Financial Times. 16 May 1997.
  21. ^ O'Shaughnessy, Lynn (July 1997). "Bernard Salick Launches a New Health Care Enterprise | Cancer Network". www.cancernetwork.com. Oncology NEWS International Vol 6 No 7. 6 (7). Retrieved March 30, 2019.
  22. ^ Rosenthal, Elisabeth (25 April 1997). "Top French AIDS Specialist Will Move to Queens College". The New York Times. Retrieved March 30, 2019.
  23. ^ StaffApr. 25, Science News (26 April 1997). "Top French AIDS Scientist Goes American". Science | AAAS. Retrieved March 30, 2019.{{cite news}}: CS1 maint: numeric names: authors list (link)
  24. ^ "CUNY's Queens College to Return $3-Million Donation". The Chronicle of Higher Education. Retrieved February 28, 2020.
  25. ^ "Salick Cardiovascular Centers, Inc. Obtains a $75 Million Series A Financing From Warburg Pincus | LifeSciencesWorld". www.lifesciencesworld.com. Retrieved 2018-07-19.
  26. ^ Harvard Public Health. "An New Name for Our New Century" (PDF). Harvard.edu. p. 67.
  27. ^ "Named Financial Aid Funds at Harvard T.H. Chan School of Public Health". Campaign for Harvard T.H. Chan School of Public Health. January 6, 2014. Retrieved March 30, 2019.
  28. ^ "Nephros Inc. Reports Departure of Director | BioSpace". BioSpace. Retrieved March 30, 2019.
  29. ^ "USET Foundation News" (PDF). uset.org. September 2010. p. 2.
  30. ^ Arenson, Karen W. (17 March 2001). "College Returns $3 Million Gift For AIDS Lab". The New York Times. Retrieved March 30, 2019.
  31. ^ "The Most Expensive Homes In America 2002". Forbes. 1 March 2002.
  32. ^ "A Hidden Valley Horse Farm Asks $32 Million". The Wall Street Journal. May 26, 2016.
  33. ^ "407 N Maple Dr". <Madison Partners. September 14, 2005.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Bernard_Salick&oldid=1240349744"